Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. COVID 19 positive case diagnosed using PCR in authorized Covid19 testing facility 2. Subjects who are asymptomatic or mild to moderately symptomatic [(cases presenting with fever or upper respiratory tract infection or pneumonia with - respiratory rate equal to or below 30 min; SpO2 equal to or above 90%) as per the clinical guidelines issued by Ministry of Health and Family Welfare] 3. Aged 18-60 years 4. Both genders 5. Individuals with or without Diabetes and Hypertension (under control) 6. High school education 7. Willing to give a written consent to participate in the study
Exclusion criteria
Exclusion criteria: 1.Severe infection requiring admission to ICU and other severe cases of COVID-19[(cases presenting with severe pneumonia with respiratory rate >30/min; SpO2 2.Any other comorbidity that prevents practice of Tele-Yoga program 3.Clinical signs suggestive of multi-organ dysfunction. 4.Score of less than 24 points on the Hindi Mental State Examination. 5.Individuals with suicidal tendencies and psychosis 6.Existing immunodeficiency or malignant disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To test the validity and feasibility of developed Tele-Yoga intervention in COVID-19 positive patients. 2.To examine the effects of the validated Tele-Yoga Program (TYP) on inflammatory markers (IL-6, TNF-α, and IFN-γ Inducible Protein-10) in individuals tested positive for COVID-19 Timepoint: baseline and 6 weeks after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To examine the efficacy of the validated TYP on T cell functions in individuals tested positive for COVID-19 Timepoint: baseline and 6 weeks after intervention;To assess the effect of TYP on clinical symptoms and number of days of hospitalization and the number of cases requiring intensive careTimepoint: baseline, 2 weeks and 6 weeks after intervention;To examine the effects of TYP on perceived stress, anxiety and depression levels in individuals tested positive for COVID-19Timepoint: baseline, 2 weeks and 6 weeks after intervention | — |
Countries
India
Contacts
National Institute of Mental Health and Neurosciences